Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Will Volatility Rise in the Fourth Quarter?
01:22 - Mouhammed Choukeir, chief investment officer at Kleinwort Benson, discusses the outlook for markets in the fourth quarter and his subsequent thoughts on investing. He speaks with Guy Johnson and Caroline Hyde on Bloomberg Television’s “On The Move.” (Source: Bloomberg)
  • Being Sanguine for EU Banks in the ‘Eye of the Storm’
  • German Finance Sector is Generally Awful, Says Choukeir
  • Could a White-Knight Deutsche Investor Make a Killing?